nodes	percent_of_prediction	percent_of_DWPC	metapath
Methadone—ABCB1—Mitomycin—stomach cancer	0.0888	0.147	CbGbCtD
Methadone—CYP3A7—Irinotecan—stomach cancer	0.0467	0.0772	CbGbCtD
Methadone—CYP3A7-CYP3A51P—Irinotecan—stomach cancer	0.0467	0.0772	CbGbCtD
Methadone—CYP2B6—Irinotecan—stomach cancer	0.0445	0.0735	CbGbCtD
Methadone—CYP2C9—Capecitabine—stomach cancer	0.038	0.0629	CbGbCtD
Methadone—CYP3A5—Irinotecan—stomach cancer	0.035	0.0579	CbGbCtD
Methadone—CYP3A7—Docetaxel—stomach cancer	0.0342	0.0566	CbGbCtD
Methadone—CYP3A7-CYP3A51P—Docetaxel—stomach cancer	0.0342	0.0566	CbGbCtD
Methadone—CYP2C8—Fluorouracil—stomach cancer	0.0323	0.0534	CbGbCtD
Methadone—CYP3A5—Docetaxel—stomach cancer	0.0257	0.0424	CbGbCtD
Methadone—CYP1A2—Fluorouracil—stomach cancer	0.025	0.0414	CbGbCtD
Methadone—CYP2B6—Doxorubicin—stomach cancer	0.0243	0.0402	CbGbCtD
Methadone—ABCB1—Irinotecan—stomach cancer	0.0228	0.0377	CbGbCtD
Methadone—CYP2C9—Fluorouracil—stomach cancer	0.0225	0.0373	CbGbCtD
Methadone—HTR3A—myenteric nerve plexus—stomach cancer	0.0177	0.213	CbGeAlD
Methadone—ABCB1—Docetaxel—stomach cancer	0.0167	0.0276	CbGbCtD
Methadone—CYP3A4—Irinotecan—stomach cancer	0.0137	0.0226	CbGbCtD
Methadone—ABCB1—Doxorubicin—stomach cancer	0.0125	0.0206	CbGbCtD
Methadone—ABCB1—Methotrexate—stomach cancer	0.0121	0.0199	CbGbCtD
Methadone—HTR3A—vagus nerve—stomach cancer	0.0118	0.142	CbGeAlD
Methadone—CYP2D6—Doxorubicin—stomach cancer	0.0117	0.0194	CbGbCtD
Methadone—CYP3A4—Docetaxel—stomach cancer	0.01	0.0165	CbGbCtD
Methadone—CYP3A4—Doxorubicin—stomach cancer	0.00746	0.0123	CbGbCtD
Methadone—CHRNA10—hematopoietic system—stomach cancer	0.00415	0.05	CbGeAlD
Methadone—CHRNA10—lymphoid tissue—stomach cancer	0.00292	0.0352	CbGeAlD
Methadone—CYP2C18—digestive system—stomach cancer	0.00199	0.0239	CbGeAlD
Methadone—HTR3A—hematopoietic system—stomach cancer	0.00192	0.0232	CbGeAlD
Methadone—OPRM1—hematopoietic system—stomach cancer	0.00176	0.0212	CbGeAlD
Methadone—CHRNA10—lymph node—stomach cancer	0.00165	0.0199	CbGeAlD
Methadone—CYP2C18—endocrine gland—stomach cancer	0.00164	0.0198	CbGeAlD
Methadone—CYP3A7—endocrine gland—stomach cancer	0.00156	0.0188	CbGeAlD
Methadone—CYP19A1—hematopoietic system—stomach cancer	0.00148	0.0178	CbGeAlD
Methadone—CYP2C18—liver—stomach cancer	0.00148	0.0178	CbGeAlD
Methadone—CYP3A7—liver—stomach cancer	0.00141	0.017	CbGeAlD
Methadone—HTR3A—digestive system—stomach cancer	0.00134	0.0161	CbGeAlD
Methadone—CYP2C19—hematopoietic system—stomach cancer	0.00122	0.0146	CbGeAlD
Methadone—CYP3A7-CYP3A51P—liver—stomach cancer	0.0012	0.0144	CbGeAlD
Methadone—CYP2C8—hematopoietic system—stomach cancer	0.00106	0.0128	CbGeAlD
Methadone—OPRM1—endocrine gland—stomach cancer	0.00101	0.0122	CbGeAlD
Methadone—CYP1A2—hematopoietic system—stomach cancer	0.000992	0.0119	CbGeAlD
Methadone—CYP3A5—hematopoietic system—stomach cancer	0.000957	0.0115	CbGeAlD
Methadone—ABCB1—blood vessel—stomach cancer	0.000955	0.0115	CbGeAlD
Methadone—CYP2B6—hematopoietic system—stomach cancer	0.000951	0.0115	CbGeAlD
Methadone—CYP2C9—hematopoietic system—stomach cancer	0.000942	0.0113	CbGeAlD
Methadone—CYP19A1—endocrine gland—stomach cancer	0.000851	0.0102	CbGeAlD
Methadone—CYP2C19—digestive system—stomach cancer	0.000845	0.0102	CbGeAlD
Methadone—Alverine—HTR1A—stomach cancer	0.000823	0.276	CrCbGaD
Methadone—CYP3A5—pancreas—stomach cancer	0.000779	0.00938	CbGeAlD
Methadone—CYP19A1—liver—stomach cancer	0.000768	0.00924	CbGeAlD
Methadone—CYP3A4—hematopoietic system—stomach cancer	0.000718	0.00865	CbGeAlD
Methadone—CYP2D6—hematopoietic system—stomach cancer	0.000707	0.00851	CbGeAlD
Methadone—CYP2C19—endocrine gland—stomach cancer	0.000698	0.00841	CbGeAlD
Methadone—CYP1A2—digestive system—stomach cancer	0.00069	0.00831	CbGeAlD
Methadone—Promethazine—HRH4—stomach cancer	0.000675	0.226	CrCbGaD
Methadone—CYP2B6—lymphoid tissue—stomach cancer	0.00067	0.00806	CbGeAlD
Methadone—CYP3A5—digestive system—stomach cancer	0.000666	0.00801	CbGeAlD
Methadone—CYP2B6—digestive system—stomach cancer	0.000662	0.00796	CbGeAlD
Methadone—CYP2C9—digestive system—stomach cancer	0.000655	0.00789	CbGeAlD
Methadone—CYP2C19—liver—stomach cancer	0.00063	0.00758	CbGeAlD
Methadone—CYP2C8—endocrine gland—stomach cancer	0.000609	0.00734	CbGeAlD
Methadone—CYP19A1—lymph node—stomach cancer	0.000588	0.00708	CbGeAlD
Methadone—CYP1A2—endocrine gland—stomach cancer	0.00057	0.00687	CbGeAlD
Methadone—CYP3A5—endocrine gland—stomach cancer	0.00055	0.00662	CbGeAlD
Methadone—CYP2C8—liver—stomach cancer	0.000549	0.00662	CbGeAlD
Methadone—CYP2B6—endocrine gland—stomach cancer	0.000547	0.00658	CbGeAlD
Methadone—CYP2C9—endocrine gland—stomach cancer	0.000541	0.00652	CbGeAlD
Methadone—CYP1A2—liver—stomach cancer	0.000514	0.00619	CbGeAlD
Methadone—ABCB1—hematopoietic system—stomach cancer	0.000509	0.00612	CbGeAlD
Methadone—CYP3A4—digestive system—stomach cancer	0.0005	0.00601	CbGeAlD
Methadone—CYP3A5—liver—stomach cancer	0.000496	0.00597	CbGeAlD
Methadone—CYP2B6—liver—stomach cancer	0.000493	0.00593	CbGeAlD
Methadone—CYP2D6—digestive system—stomach cancer	0.000492	0.00592	CbGeAlD
Methadone—CYP2C9—liver—stomach cancer	0.000488	0.00588	CbGeAlD
Methadone—ABCB1—epithelium—stomach cancer	0.000465	0.0056	CbGeAlD
Methadone—ABCB1—pancreas—stomach cancer	0.000414	0.00498	CbGeAlD
Methadone—CYP3A4—endocrine gland—stomach cancer	0.000413	0.00497	CbGeAlD
Methadone—CYP2D6—endocrine gland—stomach cancer	0.000406	0.00489	CbGeAlD
Methadone—Clotrimazole—CYP2A6—stomach cancer	0.000377	0.126	CrCbGaD
Methadone—CYP3A4—liver—stomach cancer	0.000372	0.00448	CbGeAlD
Methadone—CYP2D6—liver—stomach cancer	0.000366	0.00441	CbGeAlD
Methadone—Anorexia—Fluorouracil—stomach cancer	0.00036	0.00166	CcSEcCtD
Methadone—Visual impairment—Capecitabine—stomach cancer	0.000358	0.00165	CcSEcCtD
Methadone—ABCB1—lymphoid tissue—stomach cancer	0.000358	0.00431	CbGeAlD
Methadone—Insomnia—Irinotecan—stomach cancer	0.000357	0.00164	CcSEcCtD
Methadone—Flushing—Docetaxel—stomach cancer	0.000356	0.00164	CcSEcCtD
Methadone—Cardiac arrest—Epirubicin—stomach cancer	0.000356	0.00164	CcSEcCtD
Methadone—Cardiac failure—Doxorubicin—stomach cancer	0.000355	0.00163	CcSEcCtD
Methadone—ABCB1—digestive system—stomach cancer	0.000354	0.00426	CbGeAlD
Methadone—Hypotension—Fluorouracil—stomach cancer	0.000353	0.00163	CcSEcCtD
Methadone—Somnolence—Irinotecan—stomach cancer	0.000351	0.00162	CcSEcCtD
Methadone—Flushing—Capecitabine—stomach cancer	0.000345	0.00159	CcSEcCtD
Methadone—Chills—Docetaxel—stomach cancer	0.000344	0.00159	CcSEcCtD
Methadone—Decreased appetite—Irinotecan—stomach cancer	0.000343	0.00158	CcSEcCtD
Methadone—Arrhythmia—Docetaxel—stomach cancer	0.000343	0.00158	CcSEcCtD
Methadone—Orthostatic hypotension—Epirubicin—stomach cancer	0.000342	0.00157	CcSEcCtD
Methadone—Insomnia—Fluorouracil—stomach cancer	0.000342	0.00157	CcSEcCtD
Methadone—Hypokalaemia—Epirubicin—stomach cancer	0.000341	0.00157	CcSEcCtD
Methadone—Pain—Irinotecan—stomach cancer	0.000337	0.00155	CcSEcCtD
Methadone—Constipation—Irinotecan—stomach cancer	0.000337	0.00155	CcSEcCtD
Methadone—Somnolence—Fluorouracil—stomach cancer	0.000336	0.00155	CcSEcCtD
Methadone—Nasopharyngitis—Epirubicin—stomach cancer	0.000335	0.00154	CcSEcCtD
Methadone—Erythema—Docetaxel—stomach cancer	0.000334	0.00154	CcSEcCtD
Methadone—Chills—Capecitabine—stomach cancer	0.000333	0.00154	CcSEcCtD
Methadone—Arrhythmia—Capecitabine—stomach cancer	0.000332	0.00153	CcSEcCtD
Methadone—Cardiac arrest—Doxorubicin—stomach cancer	0.000329	0.00152	CcSEcCtD
Methadone—Decreased appetite—Fluorouracil—stomach cancer	0.000328	0.00151	CcSEcCtD
Methadone—ABCB1—bone marrow—stomach cancer	0.000326	0.00392	CbGeAlD
Methadone—Feeling abnormal—Irinotecan—stomach cancer	0.000325	0.0015	CcSEcCtD
Methadone—Erythema—Capecitabine—stomach cancer	0.000323	0.00149	CcSEcCtD
Methadone—Pain—Fluorouracil—stomach cancer	0.000323	0.00149	CcSEcCtD
Methadone—Gastrointestinal pain—Irinotecan—stomach cancer	0.000323	0.00149	CcSEcCtD
Methadone—Muscle spasms—Docetaxel—stomach cancer	0.000321	0.00148	CcSEcCtD
Methadone—Orthostatic hypotension—Doxorubicin—stomach cancer	0.000316	0.00146	CcSEcCtD
Methadone—Hypokalaemia—Doxorubicin—stomach cancer	0.000315	0.00145	CcSEcCtD
Methadone—Abdominal pain—Irinotecan—stomach cancer	0.000312	0.00144	CcSEcCtD
Methadone—Body temperature increased—Irinotecan—stomach cancer	0.000312	0.00144	CcSEcCtD
Methadone—Feeling abnormal—Fluorouracil—stomach cancer	0.000311	0.00143	CcSEcCtD
Methadone—Muscle spasms—Capecitabine—stomach cancer	0.000311	0.00143	CcSEcCtD
Methadone—Nasopharyngitis—Doxorubicin—stomach cancer	0.00031	0.00143	CcSEcCtD
Methadone—Drowsiness—Methotrexate—stomach cancer	0.000308	0.00142	CcSEcCtD
Methadone—Tremor—Capecitabine—stomach cancer	0.000303	0.0014	CcSEcCtD
Methadone—Urticaria—Fluorouracil—stomach cancer	0.0003	0.00138	CcSEcCtD
Methadone—Syncope—Docetaxel—stomach cancer	0.0003	0.00138	CcSEcCtD
Methadone—Body temperature increased—Fluorouracil—stomach cancer	0.000299	0.00138	CcSEcCtD
Methadone—Sweating—Methotrexate—stomach cancer	0.000295	0.00136	CcSEcCtD
Methadone—Palpitations—Docetaxel—stomach cancer	0.000295	0.00136	CcSEcCtD
Methadone—Weight increased—Epirubicin—stomach cancer	0.000294	0.00136	CcSEcCtD
Methadone—Loss of consciousness—Docetaxel—stomach cancer	0.000294	0.00135	CcSEcCtD
Methadone—Weight decreased—Epirubicin—stomach cancer	0.000293	0.00135	CcSEcCtD
Methadone—ABCB1—endocrine gland—stomach cancer	0.000292	0.00352	CbGeAlD
Methadone—Vertigo—Capecitabine—stomach cancer	0.000291	0.00134	CcSEcCtD
Methadone—Hypersensitivity—Irinotecan—stomach cancer	0.000291	0.00134	CcSEcCtD
Methadone—Syncope—Capecitabine—stomach cancer	0.00029	0.00134	CcSEcCtD
Methadone—Convulsion—Docetaxel—stomach cancer	0.000289	0.00133	CcSEcCtD
Methadone—Drowsiness—Epirubicin—stomach cancer	0.000288	0.00133	CcSEcCtD
Methadone—Palpitations—Capecitabine—stomach cancer	0.000286	0.00132	CcSEcCtD
Methadone—Loss of consciousness—Capecitabine—stomach cancer	0.000284	0.00131	CcSEcCtD
Methadone—Asthenia—Irinotecan—stomach cancer	0.000283	0.0013	CcSEcCtD
Methadone—Oxaprozin—PTGS2—stomach cancer	0.000279	0.0933	CrCbGaD
Methadone—Hypersensitivity—Fluorouracil—stomach cancer	0.000278	0.00128	CcSEcCtD
Methadone—Dry mouth—Docetaxel—stomach cancer	0.000278	0.00128	CcSEcCtD
Methadone—Sweating—Epirubicin—stomach cancer	0.000276	0.00127	CcSEcCtD
Methadone—Confusional state—Docetaxel—stomach cancer	0.000275	0.00127	CcSEcCtD
Methadone—Anxiety—Capecitabine—stomach cancer	0.000274	0.00126	CcSEcCtD
Methadone—Anaphylactic shock—Docetaxel—stomach cancer	0.000273	0.00126	CcSEcCtD
Methadone—Oedema—Docetaxel—stomach cancer	0.000273	0.00126	CcSEcCtD
Methadone—Weight increased—Doxorubicin—stomach cancer	0.000272	0.00126	CcSEcCtD
Methadone—Weight decreased—Doxorubicin—stomach cancer	0.000271	0.00125	CcSEcCtD
Methadone—Diarrhoea—Irinotecan—stomach cancer	0.00027	0.00124	CcSEcCtD
Methadone—Dry mouth—Capecitabine—stomach cancer	0.000269	0.00124	CcSEcCtD
Methadone—Shock—Docetaxel—stomach cancer	0.000268	0.00124	CcSEcCtD
Methadone—Pruritus—Fluorouracil—stomach cancer	0.000267	0.00123	CcSEcCtD
Methadone—Thrombocytopenia—Docetaxel—stomach cancer	0.000267	0.00123	CcSEcCtD
Methadone—Drowsiness—Doxorubicin—stomach cancer	0.000267	0.00123	CcSEcCtD
Methadone—Visual impairment—Methotrexate—stomach cancer	0.000267	0.00123	CcSEcCtD
Methadone—Confusional state—Capecitabine—stomach cancer	0.000266	0.00123	CcSEcCtD
Methadone—Tachycardia—Docetaxel—stomach cancer	0.000266	0.00123	CcSEcCtD
Methadone—Oedema—Capecitabine—stomach cancer	0.000264	0.00122	CcSEcCtD
Methadone—Bradycardia—Epirubicin—stomach cancer	0.000264	0.00121	CcSEcCtD
Methadone—ABCB1—liver—stomach cancer	0.000263	0.00317	CbGeAlD
Methadone—Dizziness—Irinotecan—stomach cancer	0.000261	0.0012	CcSEcCtD
Methadone—Anorexia—Docetaxel—stomach cancer	0.00026	0.0012	CcSEcCtD
Methadone—Shock—Capecitabine—stomach cancer	0.00026	0.0012	CcSEcCtD
Methadone—Diarrhoea—Fluorouracil—stomach cancer	0.000258	0.00119	CcSEcCtD
Methadone—Thrombocytopenia—Capecitabine—stomach cancer	0.000258	0.00119	CcSEcCtD
Methadone—Tachycardia—Capecitabine—stomach cancer	0.000258	0.00119	CcSEcCtD
Methadone—Sweating—Doxorubicin—stomach cancer	0.000256	0.00118	CcSEcCtD
Methadone—Hyperhidrosis—Capecitabine—stomach cancer	0.000255	0.00118	CcSEcCtD
Methadone—Hypotension—Docetaxel—stomach cancer	0.000255	0.00117	CcSEcCtD
Methadone—Anorexia—Capecitabine—stomach cancer	0.000252	0.00116	CcSEcCtD
Methadone—Vomiting—Irinotecan—stomach cancer	0.000251	0.00116	CcSEcCtD
Methadone—Dizziness—Fluorouracil—stomach cancer	0.00025	0.00115	CcSEcCtD
Methadone—Visual impairment—Epirubicin—stomach cancer	0.000249	0.00115	CcSEcCtD
Methadone—Rash—Irinotecan—stomach cancer	0.000249	0.00115	CcSEcCtD
Methadone—Dermatitis—Irinotecan—stomach cancer	0.000248	0.00115	CcSEcCtD
Methadone—Chills—Methotrexate—stomach cancer	0.000248	0.00114	CcSEcCtD
Methadone—Headache—Irinotecan—stomach cancer	0.000247	0.00114	CcSEcCtD
Methadone—Hypotension—Capecitabine—stomach cancer	0.000247	0.00114	CcSEcCtD
Methadone—Insomnia—Docetaxel—stomach cancer	0.000247	0.00114	CcSEcCtD
Methadone—Bradycardia—Doxorubicin—stomach cancer	0.000244	0.00112	CcSEcCtD
Methadone—Somnolence—Docetaxel—stomach cancer	0.000242	0.00112	CcSEcCtD
Methadone—Erythema—Methotrexate—stomach cancer	0.000241	0.00111	CcSEcCtD
Methadone—Flushing—Epirubicin—stomach cancer	0.00024	0.00111	CcSEcCtD
Methadone—Vomiting—Fluorouracil—stomach cancer	0.00024	0.00111	CcSEcCtD
Methadone—Insomnia—Capecitabine—stomach cancer	0.000239	0.0011	CcSEcCtD
Methadone—Rash—Fluorouracil—stomach cancer	0.000238	0.0011	CcSEcCtD
Methadone—Dermatitis—Fluorouracil—stomach cancer	0.000238	0.0011	CcSEcCtD
Methadone—Decreased appetite—Docetaxel—stomach cancer	0.000237	0.00109	CcSEcCtD
Methadone—Headache—Fluorouracil—stomach cancer	0.000237	0.00109	CcSEcCtD
Methadone—Nausea—Irinotecan—stomach cancer	0.000234	0.00108	CcSEcCtD
Methadone—Pain—Docetaxel—stomach cancer	0.000233	0.00107	CcSEcCtD
Methadone—Constipation—Docetaxel—stomach cancer	0.000233	0.00107	CcSEcCtD
Methadone—Chills—Epirubicin—stomach cancer	0.000232	0.00107	CcSEcCtD
Methadone—Arrhythmia—Epirubicin—stomach cancer	0.000231	0.00107	CcSEcCtD
Methadone—Visual impairment—Doxorubicin—stomach cancer	0.000231	0.00106	CcSEcCtD
Methadone—Decreased appetite—Capecitabine—stomach cancer	0.000229	0.00106	CcSEcCtD
Methadone—Pain—Capecitabine—stomach cancer	0.000226	0.00104	CcSEcCtD
Methadone—Constipation—Capecitabine—stomach cancer	0.000226	0.00104	CcSEcCtD
Methadone—Erythema—Epirubicin—stomach cancer	0.000225	0.00104	CcSEcCtD
Methadone—Feeling abnormal—Docetaxel—stomach cancer	0.000225	0.00104	CcSEcCtD
Methadone—Nausea—Fluorouracil—stomach cancer	0.000224	0.00103	CcSEcCtD
Methadone—Phenoxybenzamine—ADRB2—stomach cancer	0.000223	0.0747	CrCbGaD
Methadone—Gastrointestinal pain—Docetaxel—stomach cancer	0.000223	0.00103	CcSEcCtD
Methadone—Tamoxifen—CYP2A6—stomach cancer	0.000223	0.0746	CrCbGaD
Methadone—Flushing—Doxorubicin—stomach cancer	0.000222	0.00102	CcSEcCtD
Methadone—Feeling abnormal—Capecitabine—stomach cancer	0.000218	0.001	CcSEcCtD
Methadone—Muscle spasms—Epirubicin—stomach cancer	0.000217	0.000998	CcSEcCtD
Methadone—Vertigo—Methotrexate—stomach cancer	0.000216	0.000997	CcSEcCtD
Methadone—Gastrointestinal pain—Capecitabine—stomach cancer	0.000216	0.000995	CcSEcCtD
Methadone—Abdominal pain—Docetaxel—stomach cancer	0.000216	0.000993	CcSEcCtD
Methadone—Body temperature increased—Docetaxel—stomach cancer	0.000216	0.000993	CcSEcCtD
Methadone—Chills—Doxorubicin—stomach cancer	0.000215	0.00099	CcSEcCtD
Methadone—Arrhythmia—Doxorubicin—stomach cancer	0.000214	0.000986	CcSEcCtD
Methadone—Urticaria—Capecitabine—stomach cancer	0.00021	0.000966	CcSEcCtD
Methadone—Body temperature increased—Capecitabine—stomach cancer	0.000209	0.000962	CcSEcCtD
Methadone—Abdominal pain—Capecitabine—stomach cancer	0.000209	0.000962	CcSEcCtD
Methadone—Convulsion—Methotrexate—stomach cancer	0.000209	0.000961	CcSEcCtD
Methadone—Erythema—Doxorubicin—stomach cancer	0.000208	0.000961	CcSEcCtD
Methadone—Agitation—Epirubicin—stomach cancer	0.000207	0.000954	CcSEcCtD
Methadone—Trimipramine—HTR1A—stomach cancer	0.000203	0.0678	CrCbGaD
Methadone—Vertigo—Epirubicin—stomach cancer	0.000202	0.000933	CcSEcCtD
Methadone—Syncope—Epirubicin—stomach cancer	0.000202	0.000931	CcSEcCtD
Methadone—ABCB1—lymph node—stomach cancer	0.000202	0.00243	CbGeAlD
Methadone—Hypersensitivity—Docetaxel—stomach cancer	0.000201	0.000926	CcSEcCtD
Methadone—Muscle spasms—Doxorubicin—stomach cancer	0.0002	0.000924	CcSEcCtD
Methadone—Palpitations—Epirubicin—stomach cancer	0.000199	0.000918	CcSEcCtD
Methadone—Confusional state—Methotrexate—stomach cancer	0.000198	0.000913	CcSEcCtD
Methadone—Loss of consciousness—Epirubicin—stomach cancer	0.000198	0.000913	CcSEcCtD
Methadone—Anaphylactic shock—Methotrexate—stomach cancer	0.000197	0.000906	CcSEcCtD
Methadone—Asthenia—Docetaxel—stomach cancer	0.000196	0.000902	CcSEcCtD
Methadone—Convulsion—Epirubicin—stomach cancer	0.000195	0.0009	CcSEcCtD
Methadone—Hypersensitivity—Capecitabine—stomach cancer	0.000194	0.000896	CcSEcCtD
Methadone—Pruritus—Docetaxel—stomach cancer	0.000193	0.000889	CcSEcCtD
Methadone—Thrombocytopenia—Methotrexate—stomach cancer	0.000192	0.000887	CcSEcCtD
Methadone—Agitation—Doxorubicin—stomach cancer	0.000192	0.000883	CcSEcCtD
Methadone—Anxiety—Epirubicin—stomach cancer	0.000191	0.000881	CcSEcCtD
Methadone—Hyperhidrosis—Methotrexate—stomach cancer	0.00019	0.000876	CcSEcCtD
Methadone—Asthenia—Capecitabine—stomach cancer	0.000189	0.000873	CcSEcCtD
Methadone—Dry mouth—Epirubicin—stomach cancer	0.000188	0.000865	CcSEcCtD
Methadone—Vertigo—Doxorubicin—stomach cancer	0.000187	0.000863	CcSEcCtD
Methadone—Anorexia—Methotrexate—stomach cancer	0.000187	0.000863	CcSEcCtD
Methadone—Syncope—Doxorubicin—stomach cancer	0.000187	0.000862	CcSEcCtD
Methadone—Pruritus—Capecitabine—stomach cancer	0.000187	0.000861	CcSEcCtD
Methadone—Diarrhoea—Docetaxel—stomach cancer	0.000187	0.00086	CcSEcCtD
Methadone—Confusional state—Epirubicin—stomach cancer	0.000185	0.000855	CcSEcCtD
Methadone—Palpitations—Doxorubicin—stomach cancer	0.000184	0.000849	CcSEcCtD
Methadone—Phenylbutazone—PTGS2—stomach cancer	0.000184	0.0617	CrCbGaD
Methadone—Oedema—Epirubicin—stomach cancer	0.000184	0.000848	CcSEcCtD
Methadone—Anaphylactic shock—Epirubicin—stomach cancer	0.000184	0.000848	CcSEcCtD
Methadone—Hypotension—Methotrexate—stomach cancer	0.000184	0.000846	CcSEcCtD
Methadone—Loss of consciousness—Doxorubicin—stomach cancer	0.000183	0.000845	CcSEcCtD
Methadone—Shock—Epirubicin—stomach cancer	0.000181	0.000834	CcSEcCtD
Methadone—Convulsion—Doxorubicin—stomach cancer	0.000181	0.000833	CcSEcCtD
Methadone—Diarrhoea—Capecitabine—stomach cancer	0.000181	0.000832	CcSEcCtD
Methadone—Dizziness—Docetaxel—stomach cancer	0.00018	0.000831	CcSEcCtD
Methadone—Thrombocytopenia—Epirubicin—stomach cancer	0.00018	0.00083	CcSEcCtD
Methadone—Tachycardia—Epirubicin—stomach cancer	0.000179	0.000827	CcSEcCtD
Methadone—Hyperhidrosis—Epirubicin—stomach cancer	0.000178	0.000819	CcSEcCtD
Methadone—Insomnia—Methotrexate—stomach cancer	0.000178	0.000819	CcSEcCtD
Methadone—Anxiety—Doxorubicin—stomach cancer	0.000177	0.000815	CcSEcCtD
Methadone—Anorexia—Epirubicin—stomach cancer	0.000175	0.000808	CcSEcCtD
Methadone—Somnolence—Methotrexate—stomach cancer	0.000175	0.000805	CcSEcCtD
Methadone—Dizziness—Capecitabine—stomach cancer	0.000175	0.000805	CcSEcCtD
Methadone—Dry mouth—Doxorubicin—stomach cancer	0.000174	0.0008	CcSEcCtD
Methadone—Vomiting—Docetaxel—stomach cancer	0.000173	0.000799	CcSEcCtD
Methadone—Rash—Docetaxel—stomach cancer	0.000172	0.000792	CcSEcCtD
Methadone—Hypotension—Epirubicin—stomach cancer	0.000172	0.000792	CcSEcCtD
Methadone—Dermatitis—Docetaxel—stomach cancer	0.000172	0.000792	CcSEcCtD
Methadone—Confusional state—Doxorubicin—stomach cancer	0.000172	0.000791	CcSEcCtD
Methadone—Decreased appetite—Methotrexate—stomach cancer	0.000171	0.000787	CcSEcCtD
Methadone—Headache—Docetaxel—stomach cancer	0.000171	0.000787	CcSEcCtD
Methadone—Anaphylactic shock—Doxorubicin—stomach cancer	0.00017	0.000784	CcSEcCtD
Methadone—Oedema—Doxorubicin—stomach cancer	0.00017	0.000784	CcSEcCtD
Methadone—Pain—Methotrexate—stomach cancer	0.000168	0.000774	CcSEcCtD
Methadone—Vomiting—Capecitabine—stomach cancer	0.000168	0.000774	CcSEcCtD
Methadone—Shock—Doxorubicin—stomach cancer	0.000167	0.000772	CcSEcCtD
Methadone—Thrombocytopenia—Doxorubicin—stomach cancer	0.000167	0.000768	CcSEcCtD
Methadone—Rash—Capecitabine—stomach cancer	0.000166	0.000767	CcSEcCtD
Methadone—Insomnia—Epirubicin—stomach cancer	0.000166	0.000767	CcSEcCtD
Methadone—Dermatitis—Capecitabine—stomach cancer	0.000166	0.000766	CcSEcCtD
Methadone—Tachycardia—Doxorubicin—stomach cancer	0.000166	0.000765	CcSEcCtD
Methadone—Headache—Capecitabine—stomach cancer	0.000165	0.000762	CcSEcCtD
Methadone—Hyperhidrosis—Doxorubicin—stomach cancer	0.000164	0.000758	CcSEcCtD
Methadone—Somnolence—Epirubicin—stomach cancer	0.000163	0.000753	CcSEcCtD
Methadone—Anorexia—Doxorubicin—stomach cancer	0.000162	0.000748	CcSEcCtD
Methadone—Nausea—Docetaxel—stomach cancer	0.000162	0.000746	CcSEcCtD
Methadone—Feeling abnormal—Methotrexate—stomach cancer	0.000162	0.000746	CcSEcCtD
Methadone—Gastrointestinal pain—Methotrexate—stomach cancer	0.000161	0.000741	CcSEcCtD
Methadone—Decreased appetite—Epirubicin—stomach cancer	0.00016	0.000737	CcSEcCtD
Methadone—Hypotension—Doxorubicin—stomach cancer	0.000159	0.000733	CcSEcCtD
Methadone—Pain—Epirubicin—stomach cancer	0.000157	0.000725	CcSEcCtD
Methadone—Constipation—Epirubicin—stomach cancer	0.000157	0.000725	CcSEcCtD
Methadone—Nausea—Capecitabine—stomach cancer	0.000157	0.000723	CcSEcCtD
Methadone—Urticaria—Methotrexate—stomach cancer	0.000156	0.000719	CcSEcCtD
Methadone—Abdominal pain—Methotrexate—stomach cancer	0.000155	0.000716	CcSEcCtD
Methadone—Body temperature increased—Methotrexate—stomach cancer	0.000155	0.000716	CcSEcCtD
Methadone—Insomnia—Doxorubicin—stomach cancer	0.000154	0.000709	CcSEcCtD
Methadone—Feeling abnormal—Epirubicin—stomach cancer	0.000152	0.000698	CcSEcCtD
Methadone—Somnolence—Doxorubicin—stomach cancer	0.000151	0.000697	CcSEcCtD
Methadone—Gastrointestinal pain—Epirubicin—stomach cancer	0.00015	0.000693	CcSEcCtD
Methadone—Decreased appetite—Doxorubicin—stomach cancer	0.000148	0.000682	CcSEcCtD
Methadone—Urticaria—Epirubicin—stomach cancer	0.000146	0.000673	CcSEcCtD
Methadone—Pain—Doxorubicin—stomach cancer	0.000146	0.000671	CcSEcCtD
Methadone—Constipation—Doxorubicin—stomach cancer	0.000146	0.000671	CcSEcCtD
Methadone—Abdominal pain—Epirubicin—stomach cancer	0.000145	0.00067	CcSEcCtD
Methadone—Body temperature increased—Epirubicin—stomach cancer	0.000145	0.00067	CcSEcCtD
Methadone—Hypersensitivity—Methotrexate—stomach cancer	0.000145	0.000667	CcSEcCtD
Methadone—Asthenia—Methotrexate—stomach cancer	0.000141	0.00065	CcSEcCtD
Methadone—Feeling abnormal—Doxorubicin—stomach cancer	0.00014	0.000646	CcSEcCtD
Methadone—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000139	0.000641	CcSEcCtD
Methadone—Pruritus—Methotrexate—stomach cancer	0.000139	0.000641	CcSEcCtD
Methadone—Hypersensitivity—Epirubicin—stomach cancer	0.000135	0.000624	CcSEcCtD
Methadone—Urticaria—Doxorubicin—stomach cancer	0.000135	0.000623	CcSEcCtD
Methadone—Abdominal pain—Doxorubicin—stomach cancer	0.000135	0.00062	CcSEcCtD
Methadone—Body temperature increased—Doxorubicin—stomach cancer	0.000135	0.00062	CcSEcCtD
Methadone—Diarrhoea—Methotrexate—stomach cancer	0.000134	0.00062	CcSEcCtD
Methadone—Asthenia—Epirubicin—stomach cancer	0.000132	0.000608	CcSEcCtD
Methadone—Pruritus—Epirubicin—stomach cancer	0.00013	0.0006	CcSEcCtD
Methadone—Dizziness—Methotrexate—stomach cancer	0.00013	0.000599	CcSEcCtD
Methadone—Diarrhoea—Epirubicin—stomach cancer	0.000126	0.00058	CcSEcCtD
Methadone—Hypersensitivity—Doxorubicin—stomach cancer	0.000125	0.000578	CcSEcCtD
Methadone—Vomiting—Methotrexate—stomach cancer	0.000125	0.000576	CcSEcCtD
Methadone—Rash—Methotrexate—stomach cancer	0.000124	0.000571	CcSEcCtD
Methadone—Dermatitis—Methotrexate—stomach cancer	0.000124	0.000571	CcSEcCtD
Methadone—Headache—Methotrexate—stomach cancer	0.000123	0.000567	CcSEcCtD
Methadone—Asthenia—Doxorubicin—stomach cancer	0.000122	0.000563	CcSEcCtD
Methadone—Dizziness—Epirubicin—stomach cancer	0.000122	0.00056	CcSEcCtD
Methadone—Pruritus—Doxorubicin—stomach cancer	0.00012	0.000555	CcSEcCtD
Methadone—Vomiting—Epirubicin—stomach cancer	0.000117	0.000539	CcSEcCtD
Methadone—Nausea—Methotrexate—stomach cancer	0.000117	0.000538	CcSEcCtD
Methadone—Diarrhoea—Doxorubicin—stomach cancer	0.000116	0.000537	CcSEcCtD
Methadone—Rash—Epirubicin—stomach cancer	0.000116	0.000534	CcSEcCtD
Methadone—Dermatitis—Epirubicin—stomach cancer	0.000116	0.000534	CcSEcCtD
Methadone—Headache—Epirubicin—stomach cancer	0.000115	0.000531	CcSEcCtD
Methadone—Dizziness—Doxorubicin—stomach cancer	0.000113	0.000519	CcSEcCtD
Methadone—Nausea—Epirubicin—stomach cancer	0.000109	0.000503	CcSEcCtD
Methadone—Vomiting—Doxorubicin—stomach cancer	0.000108	0.000499	CcSEcCtD
Methadone—Rash—Doxorubicin—stomach cancer	0.000107	0.000494	CcSEcCtD
Methadone—Dermatitis—Doxorubicin—stomach cancer	0.000107	0.000494	CcSEcCtD
Methadone—Headache—Doxorubicin—stomach cancer	0.000107	0.000491	CcSEcCtD
Methadone—Nausea—Doxorubicin—stomach cancer	0.000101	0.000466	CcSEcCtD
Methadone—CYP3A5—Metabolism—HMOX1—stomach cancer	9.72e-06	0.000105	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—DPYD—stomach cancer	9.68e-06	0.000105	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—PIK3CA—stomach cancer	9.65e-06	0.000105	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—AKR1C3—stomach cancer	9.64e-06	0.000104	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—ERBB2—stomach cancer	9.47e-06	0.000103	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—ENO1—stomach cancer	9.47e-06	0.000103	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—PRKCB—stomach cancer	9.45e-06	0.000102	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—FADS1—stomach cancer	9.42e-06	0.000102	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—TYMP—stomach cancer	9.42e-06	0.000102	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—IL6ST—stomach cancer	9.41e-06	0.000102	CbGpPWpGaD
Methadone—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	9.4e-06	0.000102	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—ENO1—stomach cancer	9.39e-06	0.000102	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—TYMS—stomach cancer	9.37e-06	0.000102	CbGpPWpGaD
Methadone—OPRK1—GPCR downstream signaling—PIK3CA—stomach cancer	9.32e-06	0.000101	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—SERPINE1—stomach cancer	9.3e-06	0.000101	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—ALB—stomach cancer	9.3e-06	0.000101	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—GSTM1—stomach cancer	9.26e-06	0.0001	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	9.24e-06	0.0001	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—KRAS—stomach cancer	9.21e-06	9.98e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—TYMS—stomach cancer	9.16e-06	9.93e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—CD44—stomach cancer	9.13e-06	9.9e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—GSTM1—stomach cancer	9.05e-06	9.82e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—APC—stomach cancer	9.04e-06	9.8e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CXCL8—stomach cancer	8.99e-06	9.74e-05	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—PPARG—stomach cancer	8.98e-06	9.73e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—RHOA—stomach cancer	8.97e-06	9.73e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—HRAS—stomach cancer	8.93e-06	9.68e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—CD44—stomach cancer	8.91e-06	9.67e-05	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—NOS3—stomach cancer	8.89e-06	9.64e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—NOS3—stomach cancer	8.88e-06	9.63e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	8.86e-06	9.61e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—SREBF2—stomach cancer	8.83e-06	9.57e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	8.78e-06	9.52e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CDKN1B—stomach cancer	8.77e-06	9.51e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—RORA—stomach cancer	8.72e-06	9.45e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—ERCC2—stomach cancer	8.71e-06	9.44e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PPP2R1A—stomach cancer	8.7e-06	9.43e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—MAPK3—stomach cancer	8.66e-06	9.39e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—GSTT1—stomach cancer	8.56e-06	9.28e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling by GPCR—IL6—stomach cancer	8.54e-06	9.26e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—GSTP1—stomach cancer	8.53e-06	9.25e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—ERCC2—stomach cancer	8.51e-06	9.23e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CYP2A6—stomach cancer	8.46e-06	9.18e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—PIK3CA—stomach cancer	8.46e-06	9.17e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—HMOX1—stomach cancer	8.42e-06	9.13e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—CD44—stomach cancer	8.4e-06	9.11e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—IL6R—stomach cancer	8.4e-06	9.1e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CCND1—stomach cancer	8.37e-06	9.08e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—JUN—stomach cancer	8.35e-06	9.06e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—CD44—stomach cancer	8.33e-06	9.03e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—ERBB2—stomach cancer	8.31e-06	9.01e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—MAPK1—stomach cancer	8.24e-06	8.93e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—EGFR—stomach cancer	8.24e-06	8.93e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—AKR1C3—stomach cancer	8.23e-06	8.93e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—MTHFR—stomach cancer	8.19e-06	8.88e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ALDOB—stomach cancer	8.17e-06	8.86e-05	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—PTGS2—stomach cancer	8.13e-06	8.82e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—MMP9—stomach cancer	8.13e-06	8.81e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—CDKN1A—stomach cancer	8.1e-06	8.78e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	8.08e-06	8.76e-05	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—ALB—stomach cancer	8.07e-06	8.75e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—ENO1—stomach cancer	8.02e-06	8.7e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—MTHFR—stomach cancer	8e-06	8.68e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—TYMS—stomach cancer	7.93e-06	8.6e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—MAPK8—stomach cancer	7.9e-06	8.57e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	7.89e-06	8.56e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CXCL8—stomach cancer	7.88e-06	8.54e-05	CbGpPWpGaD
Methadone—OPRM1—GPCR downstream signaling—PIK3CA—stomach cancer	7.87e-06	8.54e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—SERPINE1—stomach cancer	7.86e-06	8.53e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—GSTM1—stomach cancer	7.84e-06	8.5e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—HRAS—stomach cancer	7.83e-06	8.49e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—KRAS—stomach cancer	7.78e-06	8.44e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PPP2R1A—stomach cancer	7.77e-06	8.42e-05	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—NOS3—stomach cancer	7.72e-06	8.37e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CDKN1B—stomach cancer	7.69e-06	8.34e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—GSTP1—stomach cancer	7.62e-06	8.26e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ALOX5—stomach cancer	7.6e-06	8.24e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—RHOA—stomach cancer	7.58e-06	8.22e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PPP2R1A—stomach cancer	7.58e-06	8.22e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—CAV1—stomach cancer	7.55e-06	8.19e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—APOA1—stomach cancer	7.53e-06	8.17e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—HMOX1—stomach cancer	7.51e-06	8.15e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—NOS3—stomach cancer	7.51e-06	8.14e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling by GPCR—IL6—stomach cancer	7.49e-06	8.12e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—DPYD—stomach cancer	7.47e-06	8.1e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—GSTP1—stomach cancer	7.44e-06	8.06e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—CAV1—stomach cancer	7.38e-06	8e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—ERCC2—stomach cancer	7.37e-06	7.99e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—APOA1—stomach cancer	7.36e-06	7.98e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CCND1—stomach cancer	7.34e-06	7.96e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—HMOX1—stomach cancer	7.33e-06	7.95e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—JUN—stomach cancer	7.32e-06	7.94e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—VEGFA—stomach cancer	7.3e-06	7.91e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—STAT3—stomach cancer	7.23e-06	7.83e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—PIK3CA—stomach cancer	7.15e-06	7.75e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PPP2R1A—stomach cancer	7.14e-06	7.74e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—MMP9—stomach cancer	7.13e-06	7.73e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CD44—stomach cancer	7.12e-06	7.72e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—CDKN1A—stomach cancer	7.1e-06	7.7e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—TYMS—stomach cancer	7.08e-06	7.68e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PPP2R1A—stomach cancer	7.08e-06	7.68e-05	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—PTGS2—stomach cancer	7.06e-06	7.66e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—ERBB2—stomach cancer	7.02e-06	7.61e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—GSTP1—stomach cancer	7.01e-06	7.6e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—GSTM1—stomach cancer	7e-06	7.59e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—GSTP1—stomach cancer	6.95e-06	7.53e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—MTHFR—stomach cancer	6.93e-06	7.52e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—MAPK8—stomach cancer	6.93e-06	7.51e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—TYMS—stomach cancer	6.91e-06	7.49e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—HMOX1—stomach cancer	6.91e-06	7.49e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	6.9e-06	7.49e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—MAPK3—stomach cancer	6.9e-06	7.48e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—HMOX1—stomach cancer	6.85e-06	7.43e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—GSTM1—stomach cancer	6.83e-06	7.41e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—MYC—stomach cancer	6.71e-06	7.28e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CXCL8—stomach cancer	6.66e-06	7.22e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PPARG—stomach cancer	6.64e-06	7.2e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—HRAS—stomach cancer	6.62e-06	7.17e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GSTT1—stomach cancer	6.61e-06	7.17e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—ERCC2—stomach cancer	6.58e-06	7.14e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—MAPK1—stomach cancer	6.57e-06	7.12e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—EGFR—stomach cancer	6.57e-06	7.12e-05	CbGpPWpGaD
Methadone—CYP2C18—Metabolism—PIK3CA—stomach cancer	6.54e-06	7.09e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CYP2A6—stomach cancer	6.53e-06	7.08e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—TYMS—stomach cancer	6.51e-06	7.06e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CDKN1B—stomach cancer	6.5e-06	7.05e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PPARG—stomach cancer	6.49e-06	7.04e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—TYMS—stomach cancer	6.46e-06	7e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—GSTM1—stomach cancer	6.44e-06	6.98e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—ERCC2—stomach cancer	6.42e-06	6.97e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—VEGFA—stomach cancer	6.4e-06	6.94e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—CAV1—stomach cancer	6.39e-06	6.93e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—GSTM1—stomach cancer	6.38e-06	6.92e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—APOA1—stomach cancer	6.38e-06	6.92e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—AKR1C3—stomach cancer	6.35e-06	6.89e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—STAT3—stomach cancer	6.34e-06	6.87e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling by GPCR—IL6—stomach cancer	6.33e-06	6.87e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—KRAS—stomach cancer	6.2e-06	6.73e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CCND1—stomach cancer	6.2e-06	6.73e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ENO1—stomach cancer	6.19e-06	6.71e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—JUN—stomach cancer	6.19e-06	6.71e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—MTHFR—stomach cancer	6.19e-06	6.71e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	6.11e-06	6.62e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—ERCC2—stomach cancer	6.05e-06	6.56e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—MAPK3—stomach cancer	6.05e-06	6.56e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PPP2R1A—stomach cancer	6.05e-06	6.56e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—MTHFR—stomach cancer	6.04e-06	6.55e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—MMP9—stomach cancer	6.02e-06	6.53e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—ERCC2—stomach cancer	6e-06	6.51e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—CDKN1A—stomach cancer	6e-06	6.51e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—ALB—stomach cancer	5.97e-06	6.47e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—GSTP1—stomach cancer	5.94e-06	6.44e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—MYC—stomach cancer	5.89e-06	6.38e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—MAPK8—stomach cancer	5.86e-06	6.35e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—HMOX1—stomach cancer	5.85e-06	6.35e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—ALB—stomach cancer	5.83e-06	6.33e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—MAPK1—stomach cancer	5.76e-06	6.24e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—EGFR—stomach cancer	5.76e-06	6.24e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—NOS3—stomach cancer	5.71e-06	6.19e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—CAV1—stomach cancer	5.71e-06	6.19e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—PIK3CA—stomach cancer	5.7e-06	6.18e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—APOA1—stomach cancer	5.69e-06	6.17e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—MTHFR—stomach cancer	5.69e-06	6.17e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—MTHFR—stomach cancer	5.64e-06	6.12e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PPARG—stomach cancer	5.62e-06	6.09e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—NOS3—stomach cancer	5.58e-06	6.05e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—CAV1—stomach cancer	5.57e-06	6.04e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—APOA1—stomach cancer	5.56e-06	6.03e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—TYMS—stomach cancer	5.52e-06	5.98e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—TP53—stomach cancer	5.51e-06	5.98e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CD44—stomach cancer	5.49e-06	5.95e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—GSTM1—stomach cancer	5.45e-06	5.91e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	5.45e-06	5.91e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—KRAS—stomach cancer	5.44e-06	5.9e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—VEGFA—stomach cancer	5.41e-06	5.86e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—STAT3—stomach cancer	5.36e-06	5.81e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—HRAS—stomach cancer	5.27e-06	5.72e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—CAV1—stomach cancer	5.25e-06	5.69e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—APOA1—stomach cancer	5.24e-06	5.68e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PTGS2—stomach cancer	5.22e-06	5.66e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—CAV1—stomach cancer	5.2e-06	5.64e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—APOA1—stomach cancer	5.19e-06	5.63e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—ERCC2—stomach cancer	5.13e-06	5.56e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—MAPK3—stomach cancer	5.12e-06	5.55e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PTGS2—stomach cancer	5.1e-06	5.53e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—ALB—stomach cancer	5.05e-06	5.48e-05	CbGpPWpGaD
Methadone—OPRD1—Signaling Pathways—IL6—stomach cancer	5.05e-06	5.47e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PPARG—stomach cancer	5.02e-06	5.44e-05	CbGpPWpGaD
Methadone—CYP19A1—Metabolism—PIK3CA—stomach cancer	5e-06	5.42e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—PIK3CA—stomach cancer	5e-06	5.42e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—MYC—stomach cancer	4.98e-06	5.4e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	4.97e-06	5.39e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PPARG—stomach cancer	4.9e-06	5.31e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—MAPK1—stomach cancer	4.87e-06	5.28e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—EGFR—stomach cancer	4.87e-06	5.28e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—TP53—stomach cancer	4.84e-06	5.24e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—NOS3—stomach cancer	4.83e-06	5.24e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—MTHFR—stomach cancer	4.82e-06	5.23e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PPP2R1A—stomach cancer	4.67e-06	5.06e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—HRAS—stomach cancer	4.62e-06	5.01e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PPARG—stomach cancer	4.61e-06	5e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—KRAS—stomach cancer	4.6e-06	4.98e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GSTP1—stomach cancer	4.58e-06	4.97e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PPARG—stomach cancer	4.57e-06	4.96e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—HMOX1—stomach cancer	4.52e-06	4.9e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—ALB—stomach cancer	4.51e-06	4.89e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—CAV1—stomach cancer	4.45e-06	4.82e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—APOA1—stomach cancer	4.44e-06	4.81e-05	CbGpPWpGaD
Methadone—OPRK1—Signaling Pathways—IL6—stomach cancer	4.43e-06	4.8e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PTGS2—stomach cancer	4.42e-06	4.79e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—ALB—stomach cancer	4.4e-06	4.77e-05	CbGpPWpGaD
Methadone—CYP3A7—Metabolism—PIK3CA—stomach cancer	4.34e-06	4.71e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—NOS3—stomach cancer	4.31e-06	4.68e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—TYMS—stomach cancer	4.26e-06	4.62e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	4.25e-06	4.61e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—PIK3CA—stomach cancer	4.22e-06	4.58e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—NOS3—stomach cancer	4.21e-06	4.57e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—GSTM1—stomach cancer	4.21e-06	4.56e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—ALB—stomach cancer	4.15e-06	4.5e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—ALB—stomach cancer	4.11e-06	4.46e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—TP53—stomach cancer	4.09e-06	4.43e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—NOS3—stomach cancer	3.97e-06	4.3e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ERCC2—stomach cancer	3.96e-06	4.29e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PTGS2—stomach cancer	3.95e-06	4.28e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—NOS3—stomach cancer	3.93e-06	4.27e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PPARG—stomach cancer	3.91e-06	4.24e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—HRAS—stomach cancer	3.91e-06	4.24e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PTGS2—stomach cancer	3.85e-06	4.18e-05	CbGpPWpGaD
Methadone—OPRM1—Signaling Pathways—IL6—stomach cancer	3.74e-06	4.06e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—MTHFR—stomach cancer	3.72e-06	4.03e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PTGS2—stomach cancer	3.63e-06	3.94e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PTGS2—stomach cancer	3.6e-06	3.9e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—ALB—stomach cancer	3.51e-06	3.81e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—CAV1—stomach cancer	3.43e-06	3.72e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—APOA1—stomach cancer	3.42e-06	3.71e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—NOS3—stomach cancer	3.36e-06	3.65e-05	CbGpPWpGaD
Methadone—CYP2B6—Metabolism—PIK3CA—stomach cancer	3.21e-06	3.48e-05	CbGpPWpGaD
Methadone—CYP3A5—Metabolism—PIK3CA—stomach cancer	3.14e-06	3.41e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PTGS2—stomach cancer	3.08e-06	3.33e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PPARG—stomach cancer	3.02e-06	3.27e-05	CbGpPWpGaD
Methadone—CYP2C8—Metabolism—PIK3CA—stomach cancer	2.72e-06	2.95e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—ALB—stomach cancer	2.71e-06	2.94e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—NOS3—stomach cancer	2.59e-06	2.81e-05	CbGpPWpGaD
Methadone—CYP2C19—Metabolism—PIK3CA—stomach cancer	2.43e-06	2.63e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PTGS2—stomach cancer	2.37e-06	2.57e-05	CbGpPWpGaD
Methadone—ABCB1—Metabolism—PIK3CA—stomach cancer	2.37e-06	2.57e-05	CbGpPWpGaD
Methadone—CYP2D6—Metabolism—PIK3CA—stomach cancer	2.23e-06	2.42e-05	CbGpPWpGaD
Methadone—CYP2C9—Metabolism—PIK3CA—stomach cancer	2.21e-06	2.4e-05	CbGpPWpGaD
Methadone—CYP1A2—Metabolism—PIK3CA—stomach cancer	1.89e-06	2.05e-05	CbGpPWpGaD
Methadone—CYP3A4—Metabolism—PIK3CA—stomach cancer	1.46e-06	1.58e-05	CbGpPWpGaD
